Genetics in rheumatoid arthritis

被引：12

作者：

Huizinga, TWJ ^{[1
]}

机构：

[1] Leiden Univ, Ctr Med, Dept Rheumatol, NL-2300 RC Leiden, Netherlands

来源：

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2003年 / 17卷 / 05期

关键词：

rheumatoid arthritis; genetics; HLA; whole genome scans;

D O I：

10.1016/S1521-6942(03)00040-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This chapter reviews the latest original research on the genetics of rheumatoid arthritis (RA), with a focus on its relevance for the clinical rheumatologist. The following questions will be dealt with in order to appreciate the recent progress in this field. Why is a knowledge of genetics useful for an understanding of the pathogenesis of RA? Is a knowledge of genetic risk factors relevant for day-to-day clinical practice? What methods are used for identifying genetic risk factors? Which genetic regions have been identified in susceptibility to RA? What risk factors have been identified? What are the future prospects and research agenda?

引用

页码：703 / 716

页数：14

共 79 条

[1]

[Anonymous], 1999, NAT GENET, V22, P1

[2]

Baerwald CGO, 2000, Z RHEUMATOL, V59, P29, DOI 10.1007/s003930050002

[3] Genetic analysis of multiplex rheumatoid arthritis families [J].

Bali, D ;

Gourley, S ;

Kostyu, DD ;

Goel, N ;

Bruce, I ;

Bell, A ;

Walker, DJ ;

Tran, K ;

Zhu, DK ;

Costello, TJ ;

Amos, CI ;

Seldin, MF .

GENES AND IMMUNITY, 1999, 1 (01) :28-36

[4] Clinical and immunogenetic characteristics of European multicase rheumatoid arthritis families [J].

Balsa, A ;

Barrera, P ;

Westhovens, R ;

Alves, H ;

Maenaut, K ;

Pascual-Salcedo, D ;

Cornélis, F ;

Bardin, T ;

Riente, L ;

Radstake, TRDJ ;

de Almeida, G ;

Lepage, V ;

Stravopoulos, C ;

Spaepen, M ;

Lopes-Vaz, A ;

Charron, D ;

Martinez, M ;

Prudhomme, JF ;

Migliorini, P ;

Fritz, P .

ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (06) :573-576

[5]

Barton A, 2001, ARTHRITIS RHEUM, V44, P61, DOI 10.1002/1529-0131(200101)44:1<61::AID-ANR9>3.0.CO

[6]

2-Q

[7] The thrombophilias: Well-defined risk factors with uncertain therapeutic implications [J].

Bauer, KA .

ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) :367-373

[8]

BAYLEY JP, 2003, IN PRESS RHEUMATOLOG

[9] ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN [J].

BLOEMENKAMP, KWM ;

ROSENDAAL, FR ;

HELMERHORST, FM ;

BULLER, HR ;

VANDENBROUCKE, JP .

LANCET, 1995, 346 (8990) :1593-1596

[10]

Brinkman BMN, 1997, BRIT J RHEUMATOL, V36, P516

← 1 2 3 4 5 6 7 8 →